
Bioinformatics analysis of gene and microRNA targets for fibromyalgia
Author(s) -
Yong Qiu,
Tengjiao Zhang,
LingBing Meng,
Xu-Tao Cheng,
Zhen Hua
Publication year - 2021
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/iitbcp
Subject(s) - fibromyalgia , medicine , microrna , gene , toxicogenomics , bioinformatics , disease , irritable bowel syndrome , pathogenesis , genetics , gene expression , biology
Fibromyalgia (FM) is the most common chronic pain disease in middle-aged women. Patients may also complain of migraine, irritable bowel syndrome and depression, which seriously affect their work and life, causing huge economic losses to society. However, the pathogenesis of FM is still controversial and the effect of the current treatment is far from satisfactory.